“Achieving efficient delivery of a neuroprotectant into the brain is crucial for acute intervention in neural injury,” said Dennis Liotta, Director, Emory Institute for Drug Development and Samuel Candler Dobbs Professor, Department of Chemistry. “These novel compounds may penetrate the blood brain barrier and, with further testing, could become attractive candidates used to treat stroke and TBI patients.”
Read the entire article at Cision PR News Wire
Categories
NeuroTrauma Sciences Enters Into Worldwide License Agreement with Emory University for Molecules to Treat Stroke and Traumatic Brain Injury
